2022 Q1 Form 10-Q Financial Statement

#000114036122017444 Filed on May 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $355.5M $359.7M
YoY Change -1.16% 2.57%
Cost Of Revenue $230.7M $244.1M
YoY Change -5.5% 2.31%
Gross Profit $124.8M $115.6M
YoY Change 8.0% 3.12%
Gross Profit Margin 35.12% 32.14%
Selling, General & Admin $72.06M $68.72M
YoY Change 4.86% -11.14%
% of Gross Profit 57.72% 59.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $13.06M $12.80M
YoY Change 2.0% 3.23%
% of Gross Profit 10.46% 11.07%
Operating Expenses $72.06M $68.72M
YoY Change 4.86% -11.14%
Operating Profit $52.79M $46.90M
YoY Change 12.56% 35.69%
Interest Expense $2.993M $3.433M
YoY Change -12.82% -20.29%
% of Operating Profit 5.67% 7.32%
Other Income/Expense, Net
YoY Change
Pretax Income $49.80M $43.46M
YoY Change 14.57% 43.66%
Income Tax $12.73M $11.80M
% Of Pretax Income 25.55% 27.14%
Net Earnings $37.07M $31.67M
YoY Change 17.06% 52.45%
Net Earnings / Revenue 10.43% 8.8%
Basic Earnings Per Share $0.89 $0.75
Diluted Earnings Per Share $0.88 $0.75
COMMON SHARES
Basic Shares Outstanding 41.87M 42.26M
Diluted Shares Outstanding 42.15M 42.39M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.17M $28.00M
YoY Change 14.91% 21.21%
Cash & Equivalents $32.17M $28.00M
Short-Term Investments
Other Short-Term Assets $46.08M $101.6M
YoY Change -54.64% -13.46%
Inventory $422.8M $350.3M
Prepaid Expenses
Receivables $282.3M $257.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $783.4M $737.2M
YoY Change 6.26% -3.6%
LONG-TERM ASSETS
Property, Plant & Equipment $445.3M $442.1M
YoY Change 0.71% 4.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $130.2M $114.3M
YoY Change 13.91% 22.77%
Total Long-Term Assets $1.005B $983.8M
YoY Change 2.18% 6.0%
TOTAL ASSETS
Total Short-Term Assets $783.4M $737.2M
Total Long-Term Assets $1.005B $983.8M
Total Assets $1.789B $1.721B
YoY Change 3.93% 1.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $114.9M $101.2M
YoY Change 13.5% 10.72%
Accrued Expenses $500.0K $1.900M
YoY Change -73.68% -96.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.475M $6.100M
YoY Change 22.54% -69.65%
Total Short-Term Liabilities $214.4M $198.8M
YoY Change 7.84% -0.9%
LONG-TERM LIABILITIES
Long-Term Debt $530.0M $524.2M
YoY Change 1.11% -11.05%
Other Long-Term Liabilities $68.34M $59.00M
YoY Change 15.84% 29.1%
Total Long-Term Liabilities $598.3M $583.2M
YoY Change 2.6% -8.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $214.4M $198.8M
Total Long-Term Liabilities $598.3M $583.2M
Total Liabilities $826.9M $795.4M
YoY Change 3.96% -6.45%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $961.7M $925.6M
YoY Change
Total Liabilities & Shareholders Equity $1.789B $1.721B
YoY Change 3.93% 1.67%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $37.07M $31.67M
YoY Change 17.06% 52.45%
Depreciation, Depletion And Amortization $13.06M $12.80M
YoY Change 2.0% 3.23%
Cash From Operating Activities -$892.0K $29.00M
YoY Change -103.08% -21.41%
INVESTING ACTIVITIES
Capital Expenditures -$12.74M -$14.20M
YoY Change -10.31% 51.06%
Acquisitions
YoY Change
Other Investing Activities $523.0K $4.400M
YoY Change -88.11% -2.22%
Cash From Investing Activities -$12.21M -$9.800M
YoY Change 24.62% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.67M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.93M -15.90M
YoY Change -193.92% -12.64%
NET CHANGE
Cash From Operating Activities -892.0K 29.00M
Cash From Investing Activities -12.21M -9.800M
Cash From Financing Activities 14.93M -15.90M
Net Change In Cash 1.829M 3.300M
YoY Change -44.58% -76.09%
FREE CASH FLOW
Cash From Operating Activities -$892.0K $29.00M
Capital Expenditures -$12.74M -$14.20M
Free Cash Flow $11.84M $43.20M
YoY Change -72.58% -6.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000310142
CY2022Q1 sxt Cost Of Products Sold
CostOfProductsSold
230675000
CY2021Q1 sxt Cost Of Products Sold
CostOfProductsSold
244089000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
934336000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
31668000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15139000
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.39
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16535000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2113000
CY2021Q1 sxt Nonvested Stock Issued Upon Vesting
NonvestedStockIssuedUponVesting
0
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1094000
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
11665000
CY2021Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
226000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
925646000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
938425000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
37071000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-237000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.41
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17211000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4163000
CY2022Q1 sxt Nonvested Stock Issued Upon Vesting
NonvestedStockIssuedUponVesting
0
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1178000
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
1679000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
961710000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
285000
CY2022Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
0
CY2021Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
280200000
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
143400000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
131400000
CY2021Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
1572000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
500000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
800000
CY2022Q1 sxt Number Of Portfolio Segments
NumberOfPortfolioSegments
1
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4877000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
367000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
117000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4912000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3891000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
156000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
353000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-80000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3614000
CY2022Q1 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
279400000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
355521000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
52789000
CY2022Q1 us-gaap Interest Expense
InterestExpense
2993000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49796000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
359702000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
46897000
CY2021Q1 us-gaap Interest Expense
InterestExpense
3433000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
43464000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
355521000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
359702000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
355521000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
359702000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.256
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271
CY2022Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
97000
CY2022Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
334000
CY2021Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-14903000
CY2021Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
236000
CY2022Q1 sxt Term In Which Decision Becomes Final After Issuance
TermInWhichDecisionBecomesFinalAfterIssuance
P30D
CY2022Q1 sxt Number Of Days Available To File Petition
NumberOfDaysAvailableToFilePetition
P10D
CY2020 sxt Employees Employment Period
EmployeesEmploymentPeriod
P5M

Files In Submission

Name View Source Status
0001140361-22-017444-index-headers.html Edgar Link pending
0001140361-22-017444-index.html Edgar Link pending
0001140361-22-017444.txt Edgar Link pending
0001140361-22-017444-xbrl.zip Edgar Link pending
brhc10036722_10q.htm Edgar Link pending
brhc10036722_10q_htm.xml Edgar Link completed
brhc10036722_ex31.htm Edgar Link pending
brhc10036722_ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sxt-20220331.xsd Edgar Link pending
sxt-20220331_cal.xml Edgar Link unprocessable
sxt-20220331_def.xml Edgar Link unprocessable
sxt-20220331_lab.xml Edgar Link unprocessable
sxt-20220331_pre.xml Edgar Link unprocessable